Kala Pharmaceuticals
IPOPublic · Waltham, United States · Founded 2009 · $79.5M raised
- Headquarters
- Waltham, Massachusetts
- Founded
- 2009
- Business Model
- B2B
- Website
- kalapharmaceuticals.com
- Total Funding
- $79.5M
- Last Round
- $68.0M Venture RoundApr 2016
- Rounds
- 2
- Type
- Public
About
Clinical-stage biopharma developing topical nanoparticle therapies for eye diseases, including treatments for dry eye and ocular inflammation.
Summary
Kala Pharmaceuticals is a Biotech company based in Waltham, United States, founded in 2009. It has raised $79.5M in total across 2 rounds, most recently a $68.0M Venture Round round in Apr 2016. Investors include Longitude Capital, Crown Venture Fund and Polaris Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2017
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...